Morpholino

MO1-piezo2a.2

ID
ZDB-MRPHLNO-210223-3
Name
MO1-piezo2a.2
Previous Names
None
Target
Sequence
5' - TCTGTTGCTGGATTCTGTGAATCAT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-piezo2a.2
Expressed Gene Anatomy Figures
elnb Fig. 3 from Faucherre et al., 2020
myl7 Fig. 2 from Faucherre et al., 2020
Phenotype
Phenotype resulting from MO1-piezo2a.2
Phenotype Fish Figures
aortic valve morphogenesis decreased process quality, abnormal WT + MO1-piezo2a.2 Fig. 4 from Faucherre et al., 2020
blood circulation decreased rate of continuous process, abnormal WT + MO1-piezo2a.2 Fig. 2 from Faucherre et al., 2020
bulbus arteriosus elnb expression decreased amount, abnormal WT + MO1-piezo2a.2 Fig. 3 from Faucherre et al., 2020
bulbus arteriosus decreased width, abnormal mmr2Tg; y1Tg + MO1-piezo2a.2 Fig. 2 from Faucherre et al., 2020
endothelial cell cellular response to hydrostatic pressure decreased process quality, abnormal y1Tg + MO1-piezo2a.2 Fig. 1 from Faucherre et al., 2020
endothelial cell mechanosensitive monoatomic ion channel activity decreased process quality, abnormal y1Tg + MO1-piezo2a.2 Fig. 1 from Faucherre et al., 2020
heart edematous, abnormal WT + MO1-piezo2a.2 Fig. 2 from Faucherre et al., 2020
heart contraction decreased rate of occurrence, abnormal WT + MO1-piezo2a.2 Fig. 2 from Faucherre et al., 2020
heart looping decreased process quality, abnormal WT + MO1-piezo2a.2 Fig. 2 from Faucherre et al., 2020
ventriculo bulbo valve malformed, abnormal WT + MO1-piezo2a.2 Fig. 4 from Faucherre et al., 2020
Phenotype of all Fish created by or utilizing MO1-piezo2a.2
Phenotype Fish Conditions Figures
heart contraction decreased rate of occurrence, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
bulbus arteriosus decreased width, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
heart edematous, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
aortic valve morphogenesis decreased process quality, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 4 from Faucherre et al., 2020
bulbus arteriosus elnb expression decreased amount, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 3 from Faucherre et al., 2020
blood circulation decreased rate of continuous process, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
ventriculo bulbo valve malformed, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 4 from Faucherre et al., 2020
heart looping decreased process quality, abnormal WT + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
endothelial cell mechanosensitive monoatomic ion channel activity decreased process quality, abnormal y1Tg + MO1-piezo2a.2 standard conditions Fig. 1 from Faucherre et al., 2020
endothelial cell cellular response to hydrostatic pressure decreased process quality, abnormal y1Tg + MO1-piezo2a.2 standard conditions Fig. 1 from Faucherre et al., 2020
bulbus arteriosus decreased width, abnormal mmr2Tg; y1Tg + MO1-piezo2a.2 standard conditions Fig. 2 from Faucherre et al., 2020
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.